What Is the MaxLinear, Inc (MXL) Class Action Lawsuit About?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MaxLinear, Inc (“MaxLinear” or “the Company”) (NYSE: MXL). Investors who purchased MaxLinear securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether MaxLinear has violated federal securities laws.
Investigation Details
On July 24, 2024, MaxLinear issued a press release announcing its second quarter 2024 results, including net revenue for the quarter amounting to just $92 million, down 50% year-over-year. The Company attributed this decline, at least in part, to a prolonged burn-off of excess customer inventory, leading to weakened demand. Following this news, MaxLinear’s stock price fell $8.27 per share, or 37.1%, to close at $14.02 on July 25, 2024.
What’s Next?
If you are aware of any facts relating to this investigation or purchased MaxLinear securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
How Did MaxLinear, Inc (MXL) Stock React to the Disclosures?
How Is BG&G Representing Investors in Securities Class Actions?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”